All Cancer Microbiology articles – Page 4
-
NewsResearchers take inspiration from viruses to improve delivery of nucleic acid-based therapies to cancer cells
A researcher is developing a patent-pending platform technology that mimics the dual-layer structure of viruses to deliver nucleic acid (NA)-based therapies to targeted cancer cells.
-
NewsNew study reveals metabolites key to faster intestinal recovery for cancer patients
A collaborative study has uncovered how metabolites drive communication between gut microbes and human cells to aid intestinal recovery after chemotherapy. This research offers new hope for enhancing cancer treatment outcomes.
-
NewsSphingomyelins (TFSM) can visualise Chlamydia inclusions within infected human cells
Researchers have succeeded in developing a sphingomyelin derivative that can be used to visualise the distribution of sphingomyelin and the activity of sphingomyelinase in infection processes.
-
NewsInnovations in cancer treatment through targeted bacterial vaccines
Scientists outline efforts to create an antibacterial vaccine capable of eliciting robust immune responses to selectively eradicate Fusobacterium nucleatum while preserving other microbiota.
-
NewsNew vaccine against cervical cancer combines prophylactic and therapeutic activity
Scientists at the German Cancer Research Center (DKFZ) have developed a completely new vaccination concept with a new vaccine against cancer-causing human papillomaviruses (HPV).
-
NewsGut microbes implicated in bladder cancer
A new study shows that gut bacteria can metabolise carcinogens and cause them to accumulate in distant organs, leading to tumour development.
-
NewsStudy says new drug shows promise in clearing HIV from brain
An experimental drug originally developed to treat cancer may help clear HIV from infected cells in the brain, according to a new study.
-
NewsFecal matter transplant helped patients with gastrointestinal cancers overcome resistance to immunotherapy treatment
Findings from a small, proof-of-concept clinical trial have suggested that fecal microbiota transplants (FMTs) can boost the effectiveness of immunotherapy in a range of gastrointestinal cancers.
-
NewsPanel issues first guidelines to prevent anal cancer in people with HIV
Results from a national study have informed the first guidelines at the federal level in the United States to detect and treat anal cancer precursor lesions in people with HIV to reduce the risk of developing anal cancer.
-
NewsStudy shows ancient viruses fuel modern-day cancers
When reawakened, endogenous retroviruses can play a critical role in helping cancer survive and thrive. A new study also suggests that silencing certain endogenous retroviruses can make cancer treatments work better.
-
NewsResearchers develop noninvasive urine test for early detection of cervical cancer virus proteins
A new urine test can detect HPV16 E7 proteins, which are critical markers of cervical cancer risk, at extremely low levels, meaning women may be able to screen for cervical cancer without the discomfort and inconvenience of a traditional Pap test.
-
CareersConnecting with microbiologists and presenting research: Oluwole Owoyemi reports back from ASM 2024
Medical microbiologist Oluwole Owoyemi of Achievers University Owo and Federal University of Technology, Akure, reports back from ASM MICROBE 2024 after being awarded a Scientific Event Travel Grant by Applied Microbiology International.
-
NewsCancer drug could be repurposed to fight Covid-19
Twelve years ago, cancer researchers identified a molecule that helps cancer cells survive by shuttling damaging inflammatory cells into tumor tissue. In new research, they show that the same molecule does the same thing in lung tissue infected with COVID-19.
-
NewsChanging the gut microbiome boosts health outcomes for people newly diagnosed with metastatic kidney cancer
Researchers have developed a novel use of biotherapeutic product CBM588 in the treatment of cancer; new research suggests the agent adjusts people’s microbiome, possibly leading to enhanced effectiveness of FDA-approved cancer immunotherapies.
-
NewsBreakthrough research makes cancer-fighting viral agent more effective
Researchers from Aarhus University have made a significant breakthrough by discovering that the drug 4-OI can enhance the effectiveness of a cancer-fighting viral agent. This may lead to treatment of cancers that are otherwise resistant to therapies.
-
NewsResearchers harness intratumoral microbiome against colorectal cancer
Scientists have established a microbiota-targeted drug delivery system that exhibits high efficiency in colorectal cancer targeting and colon retention.
-
NewsResearchers deploy E coli to selectively target tumor cells
Scientists explore how an engineered bacterium limits tumor growth and maximizes targeted anticancer drug delivery.
-
NewsChemotherapy disrupts gut microbiome in patients with breast cancer
Patients treated with chemotherapy who showed decreases in cognitive performance also had reductions in the diversity of their gut microbiome, a new study has found.
-
NewsOncolytic virus inhibits liver cancer growth by inducing cell cycle arrest and apoptosis
Researchers have found that administration of an oncolytic virus, Senecavirus A, effectively suppressed hepatocellular carcinoma proliferation and growth in a mouse model placed beneath the skin by triggering apoptosis.
-
NewsScientists map role of Porphyromonas gingivalis in chemotherapy resistance
A new paper describes how the bacterium Porphyromonas gingivalis interferes with chemotherapy-induced mitophagy, allowing oral cancer tumors to become resistant to the drug’s effects.